cobalt has been researched along with von Hippel-Lindau Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Axelrod, JH; Heyman, SN; Khamaisi, M; Koesters, R; Meidan, R; Mimura, I; Nangaku, M; Rosen, S; Rosenberger, C; Shina, A; Skarzinski, G; Toukan, H; Walkinshaw, G | 1 |
| Choi, JW; Kang, GH; Liu, JO; Park, SC; Youn, HD | 1 |
| Chang, GW; Clifford, SC; Cockman, ME; Maher, ER; Maxwell, PH; Pugh, CW; Ratcliffe, PJ; Vaux, EC; Wiesener, MS; Wykoff, CC | 1 |
3 other study(ies) available for cobalt and von Hippel-Lindau Disease
| Article | Year |
|---|---|
Endothelin-converting enzyme is a plausible target gene for hypoxia-inducible factor.
Topics: Animals; Aspartic Acid Endopeptidases; Cell Hypoxia; Cells, Cultured; Cobalt; Dioxygenases; Endothelin-Converting Enzymes; Human Umbilical Vein Endothelial Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Introns; Kidney Tubules, Proximal; Male; Metalloendopeptidases; Mice; Mice, Inbred BALB C; Mice, Knockout; Mimosine; Oligonucleotide Array Sequence Analysis; Prolyl-Hydroxylase Inhibitors; Promoter Regions, Genetic; Rats; Rats, Sprague-Dawley; Signal Transduction; STAT3 Transcription Factor; Transcription, Genetic; von Hippel-Lindau Disease | 2015 |
Nur77 activated by hypoxia-inducible factor-1alpha overproduces proopiomelanocortin in von Hippel-Lindau-mutated renal cell carcinoma.
Topics: Amino Acid Substitution; Base Sequence; Carcinoma, Renal Cell; Cobalt; DNA Primers; DNA-Binding Proteins; Genes, Tumor Suppressor; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Kidney Neoplasms; Mutation; Nuclear Receptor Subfamily 4, Group A, Member 1; Pro-Opiomelanocortin; Promoter Regions, Genetic; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid; Reverse Transcriptase Polymerase Chain Reaction; Transcription Factors; Transcription, Genetic; Tumor Cells, Cultured; Tumor Suppressor Proteins; Ubiquitin-Protein Ligases; von Hippel-Lindau Disease; Von Hippel-Lindau Tumor Suppressor Protein | 2004 |
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.
Topics: Cell Hypoxia; Cobalt; Cysteine Endopeptidases; DNA-Binding Proteins; Gene Expression Regulation; Genes, Tumor Suppressor; HeLa Cells; Humans; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Iron Chelating Agents; Ligases; Multienzyme Complexes; Neovascularization, Pathologic; Nuclear Proteins; Oxygen; Proteasome Endopeptidase Complex; Protein Binding; Proteins; Response Elements; Transcription Factors; Transfection; Tumor Cells, Cultured; Tumor Suppressor Proteins; Ubiquitin-Protein Ligases; von Hippel-Lindau Disease; Von Hippel-Lindau Tumor Suppressor Protein | 1999 |